By cutting and pasting and not linking the article you are essentially modifying the story because you left out the last paragraph in the story.
The lone loser of the DEA decision
Perhaps the biggest loser here is the individual investor looking to take advantage of the marijuana industry's incredible growth.
According to ArcView Market Research, a cannabis research firm, legal marijuana sales hit $5.4 billion in 2015, and they're slated to grow by roughly 30% per year throughout the remainder of the decade. If this trend were to continue, then legal marijuana sales would total nearly $22 billion by 2020. An investment that could grow at 30% per year for five straight years is a real rarity for stock investors, so you can imagine how closely some investors are watching the marijuana industry. Unfortunately, keeping cannabis as a Schedule 1 substance will probably keep big business from gaining substantial market share within the industry. This leaves investors little to no opportunity to profit from the growing legal marijuana market.
Making matters worse for investors is the fact that the vast majority of publicly traded marijuana stocks are penny stocks that trade on over-the-counter exchanges. While reporting standards are improving on the OTC exchanges, it can still be difficult to get accurate financial information on cannabis stocks. Nonetheless, losses remain common among marijuana stocks, and that's all the more reason to watch the advancement of the industry safely from the sidelines.
News 
Market Data 
Discover 
